Deepa Bhojwani Selected Research

Drug Therapy (Chemotherapy)

10/2023	INSPIRED Symposium Part 4A: Access to CAR T Cell Therapy in Unique Populations with B Cell Acute Lymphoblastic Leukemia.
1/2023	Asparaginase toxicity in Hispanic adult and pediatric patients with acute lymphoblastic leukemia: current understanding.
6/2022	Hispanic ethnicity and the rs4880 variant in SOD2 are associated with elevated liver enzymes and bilirubin levels in children receiving asparaginase-containing chemotherapy for acute lymphoblastic leukemia.
1/2022	Decitabine and vorinostat with FLAG chemotherapy in pediatric relapsed/refractory AML: Report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium.
1/2020	Integrin α6 mediates the drug resistance of acute lymphoblastic B-cell leukemia.
1/2020	Decitabine and Vorinostat with Chemotherapy in Relapsed Pediatric Acute Lymphoblastic Leukemia: A TACL Pilot Study.
1/2018	Predictors of hepatotoxicity and pancreatitis in children and adolescents with acute lymphoblastic leukemia treated according to contemporary regimens.
10/2017	Phase 1 study of the anti-CD22 immunotoxin moxetumomab pasudotox for childhood acute lymphoblastic leukemia.
10/2017	A neoplasm with FIP1L1-PDGFRA fusion presenting as pediatric T-cell lymphoblastic leukemia/lymphoma without eosinophilia.
9/2017	The PI3Kδ Inhibitor Idelalisib Inhibits Homing in an in Vitro and in Vivo Model of B ALL.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Deepa Bhojwani Research Topics

Disease

43	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2024 - 01/2003
19	Leukemia 01/2024 - 01/2009
14	Neoplasms (Cancer) 11/2023 - 01/2003
10	Residual Neoplasm 10/2023 - 01/2009
7	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2024 - 01/2007
6	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 09/2011
5	Lymphoma (Lymphomas) 01/2024 - 08/2014
2	Capillary Leak Syndrome 01/2021 - 10/2017
2	Neurologic Manifestations (Neurological Manifestations) 11/2020 - 09/2011
2	Obesity 01/2018 - 09/2011
2	Pancreatitis 01/2018 - 01/2016
2	Leukoencephalopathies 10/2016 - 03/2014
2	Philadelphia Chromosome 05/2014 - 01/2009
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2023
1	Hypertriglyceridemia 01/2023
1	Down Syndrome (Down's Syndrome) 01/2022
1	Cytopenia 01/2022
1	Hyperbilirubinemia 01/2022
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2022
1	Neuroinflammatory Diseases 12/2021
1	Blindness (Hysterical Blindness) 07/2021
1	Seizures (Absence Seizure) 07/2021
1	B-Cell Leukemia (Leukemia, B Cell) 01/2020
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2019
1	Venous Thromboembolism 01/2018
1	Thrombotic Microangiopathies 10/2017
1	Hemolytic-Uremic Syndrome 10/2017
1	Hypoalbuminemia 10/2017
1	Weight Gain 10/2017
1	Eosinophilia 10/2017
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2016

Drug/Important Bio-Agent (IBA)

5	GlucocorticoidsIBA 12/2021 - 01/2009
4	RNA (Ribonucleic Acid)IBA 11/2023 - 08/2014
4	blinatumomabIBA 01/2022 - 12/2016
4	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 05/2006
3	Chimeric Antigen ReceptorsIBA 01/2023 - 01/2018
3	Asparaginase (Elspar)FDA Link 01/2023 - 01/2016
3	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023 - 10/2017
3	Etoposide (VP 16)FDA LinkGeneric 01/2023 - 01/2012
3	Vorinostat FDA Link 10/2022 - 01/2020
3	Decitabine FDA Link 10/2022 - 01/2020
3	Inotuzumab OzogamicinIBA 01/2022 - 01/2019
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2003
3	immunotoxin HA22IBA 01/2021 - 10/2017
3	Tyrosine Kinase InhibitorsIBA 10/2017 - 01/2009
2	Cytarabine (Cytosar-U)FDA LinkGeneric 10/2022 - 01/2012
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 10/2013
2	Clofarabine (Clolar)FDA Link 01/2021 - 01/2012
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 01/2012
2	Methotrexate (Mexate)FDA LinkGeneric 11/2020 - 03/2014
2	Immunotoxins (Immunotoxin)IBA 01/2020 - 10/2017
2	ProteomeIBA 01/2007 - 05/2006
1	NivolumabIBA 01/2024
1	Azacitidine (5 Azacytidine)FDA Link 01/2024
1	2-mercaptopurineIBA 01/2024
1	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 01/2024
1	tisagenlecleucelIBA 10/2023
1	Vincristine (Oncovin)FDA LinkGeneric 01/2023
1	ibrutinibIBA 01/2023
1	Carboplatin (JM8)FDA LinkGeneric 01/2023
1	Rituximab (Mabthera)FDA Link 01/2023
1	Ifosfamide FDA LinkGeneric 01/2023
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 01/2023
1	fludarabineIBA 10/2022
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2022
1	BilirubinIBA 06/2022
1	EnzymesIBA 06/2022
1	LigandsIBA 01/2022
1	Integrin alpha4beta1 (VLA-4)IBA 01/2022
1	CD19 AntigensIBA 01/2022
1	Protein Isoforms (Isoforms)IBA 01/2022
1	Anticonvulsants (Antiepileptic Drugs)IBA 12/2021
1	Cytotoxins (Cytolysins)IBA 08/2021
1	Gemtuzumab (Mylotarg)FDA Link 08/2021
1	Immunoconjugates (Immunoconjugate)IBA 08/2021
1	Bendamustine Hydrochloride FDA Link 01/2021
1	Genetic Markers (Genetic Marker)IBA 01/2021
1	ChromatinIBA 01/2021
1	PanobinostatIBA 11/2020
1	IntegrinsIBA 01/2020
1	AntimetabolitesIBA 01/2020
1	Transaminases (Aminotransferases)IBA 10/2017
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 10/2017
1	Lysine AcetyltransferasesIBA 01/2017
1	Histone Deacetylase InhibitorsIBA 01/2017
1	Histones (Histone)IBA 01/2017
1	NucleotidesIBA 04/2016
1	purineIBA 01/2016
1	Carboxypeptidases A (Carboxypeptidase A)IBA 01/2016
1	Caspase 1 (ICE Protease)IBA 06/2015

Therapy/Procedure

27	Therapeutics 11/2023 - 01/2003
17	Drug Therapy (Chemotherapy) 10/2023 - 01/2009
3	Remission Induction 04/2015 - 02/2011
2	Hematopoietic Stem Cell Transplantation 01/2022 - 01/2019
2	Combination Drug Therapy (Combination Chemotherapy) 01/2019 - 01/2012
1	Immunotherapy 12/2021
1	Activities of Daily Living (ADL) 07/2021
1	Heart Transplantation (Grafting, Heart) 07/2021
1	Radiotherapy 11/2020
1	Investigational Therapies (Experimental Therapy) 09/2017